Andre M. Kallab

1.3k total citations
17 papers, 285 citations indexed

About

Andre M. Kallab is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Andre M. Kallab has authored 17 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 5 papers in Genetics. Recurrent topics in Andre M. Kallab's work include Estrogen and related hormone effects (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Advanced Breast Cancer Therapies (2 papers). Andre M. Kallab is often cited by papers focused on Estrogen and related hormone effects (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Advanced Breast Cancer Therapies (2 papers). Andre M. Kallab collaborates with scholars based in United States, France and Singapore. Andre M. Kallab's co-authors include Anand P. Jillella, Patricia V. Schoenlein, Celalettin Üstün, Michael W. Felz, John T. Barrett, Alan G. Porter, Russell Burgess, Min Hou, Yayun Liang and John Barrett and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and American Journal of Hematology.

In The Last Decade

Andre M. Kallab

17 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andre M. Kallab United States	9	92	67	64	54	53	17	285
Pierre Schneider France	12	163 1.8×	67 1.0×	87 1.4×	24 0.4×	55 1.0×	20	343
Sara R. Rashkin United States	8	88 1.0×	45 0.7×	134 2.1×	122 2.3×	29 0.5×	16	379
Toshiaki Ishida Japan	11	112 1.2×	78 1.2×	180 2.8×	41 0.8×	28 0.5×	51	439
Teruaki Akaogi Japan	11	50 0.5×	30 0.4×	62 1.0×	49 0.9×	59 1.1×	19	331
Ci Pan China	14	107 1.2×	35 0.5×	70 1.1×	21 0.4×	29 0.5×	37	405
Kazunori Murai Japan	12	69 0.8×	40 0.6×	93 1.5×	19 0.4×	68 1.3×	48	330
Ray Lonsdale United Kingdom	11	68 0.7×	34 0.5×	44 0.7×	33 0.6×	19 0.4×	22	306
Carole Charlot France	10	60 0.7×	35 0.5×	141 2.2×	34 0.6×	51 1.0×	13	396
Mikiya Endo Japan	11	47 0.5×	28 0.4×	114 1.8×	56 1.0×	50 0.9×	27	350
Jean Jacques Sotto France	6	57 0.6×	29 0.4×	101 1.6×	28 0.5×	72 1.4×	6	327

Countries citing papers authored by Andre M. Kallab

Since Specialization

Citations

This map shows the geographic impact of Andre M. Kallab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andre M. Kallab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andre M. Kallab more than expected).

Fields of papers citing papers by Andre M. Kallab

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andre M. Kallab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andre M. Kallab. The network helps show where Andre M. Kallab may publish in the future.

Co-authorship network of co-authors of Andre M. Kallab

This figure shows the co-authorship network connecting the top 25 collaborators of Andre M. Kallab. A scholar is included among the top collaborators of Andre M. Kallab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andre M. Kallab. Andre M. Kallab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Yardley, Denise A., Suzanne F. Jones, N. W. Peacock, et al.. (2015). Abstract OT2-1-07: A phase II study with orteronel as monotherapy in patients with androgen receptor (AR) expressing metastatic breast cancer (MBC). Cancer Research. 75(9_Supplement). OT2–1. 1 indexed citations

Schoenlein, Patricia V., Min Hou, Julia S. Samaddar, et al.. (2007). Downregulation of retinoblastoma protein is involved in the enhanced cytotoxicity of 4-hydroxytamoxifen plus mifepristone combination therapy versus antiestrogen monotherapy of human breast cancer. International Journal of Oncology. 31(3). 643–55. 16 indexed citations

Kallab, Andre M., et al.. (2005). A Phase II Study of Weekly Paclitaxel and Carboplatin in Previously Untreated Patients with Advanced Non-Small-Cell Lung Cancer. Medical Oncology. 22(2). 145–152. 6 indexed citations

Williams, Hadyn T., et al.. (2004). F-18 FDG Positron Emission Tomography Imaging of Rare Soft Tissue Sarcomas. Clinical Nuclear Medicine. 29(9). 581–584. 13 indexed citations

Barrett, John T., et al.. (2004). Mifepristone Induces Growth Arrest, Caspase Activation, and Apoptosis of Estrogen Receptor-Expressing, Antiestrogen-Resistant Breast Cancer Cells. Clinical Cancer Research. 10(15). 5215–5225. 50 indexed citations

Jillella, Anand P., et al.. (2003). Infectious Complications in Patients Receiving Mobilization Chemotherapy for Autologous Peripheral Blood Stem Cell Collection. Journal of Hematotherapy & Stem Cell Research. 12(2). 155–160. 11 indexed citations

Liang, Yayun, et al.. (2003). Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: A role for TGFβ1. International Journal of Oncology. 23(2). 369–80. 32 indexed citations

Üstün, Celalettin, et al.. (2002). Rituximab Provides Durable Remission in a Patient with Refractory Aggressive Diffuse B-cell Lymphoma Failing Salvage Chemotherapy. Leukemia & lymphoma. 43(11). 2235–2236. 1 indexed citations

Jillella, Anand P., et al.. (2002). Adult T-Cell Leukemia/lymphoma: A Rare Case in the USA and Review of the Literature. Leukemia & lymphoma. 43(1). 127–132. 5 indexed citations

10.

Majmundar, Monil, et al.. (2002). Leukemic Leptomeningeal Involvement in Stage 0 and Stage 1 Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 43(1). 199–201. 24 indexed citations

11.

Jillella, Anand P., et al.. (2002). Treatment of a patient with end‐stage renal disease with Rituximab: Pharmacokinetic evaluation suggests Rituximab is not eliminated by hemodialysis. American Journal of Hematology. 71(3). 219–222. 53 indexed citations

12.

Kallab, Andre M. & Anand P. Jillella. (2001). Tumor Lysis Syndrome in Small Cell Lung Cancer. Medical Oncology. 18(2). 149–152. 13 indexed citations

13.

Kallab, Andre M., et al.. (2001). Successful Treatment of an Intractable Case of Hereditary Basal Cell Carcinoma Syndrome With Paclitaxel. Archives of Dermatology. 137(6). 827–827. 6 indexed citations

14.

Dalton, Rory R. & Andre M. Kallab. (2001). Chemoprevention of Breast Cancer. Southern Medical Journal. 94(1). 7–15. 3 indexed citations

15.

Felz, Michael W., et al.. (2001). Anal melanoma: an aggressive malignancy masquerading as hemorrhoids.. PubMed. 94(9). 880–5. 36 indexed citations

16.

Jillella, Anand P., et al.. (2000). Non-Hodgkin's Lymphoma Presenting as Anasarca: Probably Mediated by Tumor Necrosis Factor Alpha (TNF-α). Leukemia & lymphoma. 38(3-4). 419–422. 8 indexed citations

17.

Kallab, Andre M., et al.. (1997). Anemia secondary to low erythropoietin in a patient with normal renal function.. PubMed. 64(6). 406–8. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact